Payment processing for telemedicine and online prescription services.

Why telemedicine payments are high-risk

Telemedicine combines three things acquiring banks each treat carefully: regulated healthcare, subscription billing, and, for many services, prescription fulfilment. Recurring consultation and refill billing generates disputes at rates above general retail. Practitioner licensing has to hold up in every market a service operates in. Patient data brings GDPR into scope.

Certain treatment areas attract extra scrutiny. Weight-loss medication, including GLP-1 programs, hormone therapy, erectile-dysfunction treatment, and mental-health prescribing all sit under closer acquirer review because of claim sensitivity and chargeback history. A processor that does not understand the model tends to decline rather than underwrite it properly.

The subscription mechanics make it worse. A patient signs up for a monthly consultation or a refill plan, forgets about it, sees the charge months later, and disputes it as unauthorised. Weight-loss and hormone programs, where results are gradual and expectations are high, see this pattern most. Each dispute counts toward the ratio the card networks monitor, and a processor without a plan for managing that ratio simply drops the account when it climbs.

Because the category blends healthcare and subscriptions, many mainstream processors are cautious or decline outright, and the ones that approve often route through a single acquirer with no fallback.